Brief: IBA Says The Lancet Recommends Proton Therapy As New Standard Of Care For Patients With Oropharyngeal Cancer
Dec 15 (Reuters) - Ion Beam Applications SA IBAB.BR: THE LANCET PUBLISHES STUDY RECOMMENDING PROTON THERAPY AS NEW STANDARD OF CARE FOR PATIENTS WITH OROPHARYNGEAL CANCER Source text: ID:nGNE9lyhNV Further company coverage: IBAB.BR (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Ion Beam Applications SA
See all newsBrief: IBA Signs Contract With Government Of Assam For India's State-Run Proton Therapy Center
Brief: Iba Signs Contract For Be Efficient Sterilization Solution In Germany
Brief: IBA Says First Patient Treated In C-Flash-01 Conformalflash Clinical Trial
Brief: IBA Selected To Support The US Expansion Of Radiopharmaceutical Producer
Brief: IBA And Telix Strengthen Ties Through Agreement To Distribute ARTMS QIS